SIS Ventures

SIS Ventures is a venture capital fund based in Edinburgh, United Kingdom, focused on supporting high-impact organizations through mission-aligned investments. The fund aims to become a leading partner for social entrepreneurs by providing access to capital that generates both financial returns and positive social or environmental outcomes. SIS Ventures primarily invests in early-stage companies in Scotland, seeking minority stakes and prioritizing purpose-driven ventures. Through its investments, SIS Ventures strives to foster growth and sustainability within the social enterprise sector.

Rob Halliday

Senior Investment Manager

Siobhan Moore

Investment Manager

16 past transactions

Solasta Bio

Seed Round in 2023
Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.

Dxcover

Series A in 2023
It is our mission to be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life. Dxcover are an award-winning team, dedicated to developing liquid biopsies for early detection of cancer and other diseases. A University of Strathclyde spinout in 2019 under the name ClinSpec Diagnostics, and rebranded as Dxcover Limited in 2021. To date, Dxcover have secured £5.1m of funding, and have successfully completed two ground-breaking clinical studies on detection of brain cancer and are currently developing our platform for the detection of commonly occurring cancers.

Nebu~Flow

Seed Round in 2022
Nebu~Flow developing the next generation of nebulizers to enable the delivery of life-changing treatments.

Carcinotech

Seed Round in 2022
Carcinotech is focused on treating cancers and is based at the Roslin Innovation Centre on the outskirts of Edinburgh.

Good-Loop

Series A in 2022
Good-Loop converts advertising money into funding for social causes in a way that makes online advertising more effective, more rewarding and more ethical. We distribute video ads across our network of quality online publishers. The Good-Loop ad player will never auto-play or interrupt but if you choose to, you can opt-in to watch an advert and then donate 50% of the advertisers' money to your chosen social cause. But Good-Loop isn't just good for the world, it's also good for the advertisers' bottom line. The average completed view rate on YouTube is 30% and on Good-Loop it’s 61% – over double the engagement, for the same price. Good-Loop was part of the Collider Startup Accelerator Program 2017, and winner for their 2017 Demo Day - http://collider.io/

Talking Medicines

Venture Round in 2022
Talking Medicines Limited is a data technology company based in Glasgow and London that specializes in capturing and structuring the patient voice regarding medications. Utilizing advanced artificial intelligence, machine learning, and natural language processing, the company collects data from real-world conversations, social media, and connected devices to understand patient behaviors and sentiments. Its flagship application, Medsmart, gathers insights on how and why individuals take their medications. Talking Medicines offers a suite of solutions, including a real-world persona data service for ongoing updates, a digital focus group tool for surveys and A/B testing, and custom solutions tailored to specific pharmaceutical needs. The company primarily serves the pharmaceutical and healthcare sectors, helping them measure patient confidence and identify trends to enhance marketing strategies. Established in 2013 and initially known as Virtual Genie Limited, the company rebranded in December 2015.

Trojan Energy

Venture Round in 2022
Trojan Energy Limited provides charging infrastructure solutions for electric vehicles worldwide. The company offers on-street flat and flush electric vehicle charging points. Trojan Energy Limited was incorporated in 2016 and is based in Stonehaven, United Kingdom.

EnteroBiotix

Series A in 2021
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. The company's offerings include developing and advancing novel microbiome modulating drugs composed of bacterial communities derived directly from the human gastrointestinal tract associated with imbalances of bacteria in the human gut, enabling physicians to prevent and treat debilitating infections and diseases.

Trojan Energy

Series A in 2021
Trojan Energy Limited provides charging infrastructure solutions for electric vehicles worldwide. The company offers on-street flat and flush electric vehicle charging points. Trojan Energy Limited was incorporated in 2016 and is based in Stonehaven, United Kingdom.

Solasta Bio

Seed Round in 2021
Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.

Cyan Forensics

Series A in 2021
CYAN FORENSICS Ltd. develops and markets tools for digital forensics in law enforcement. Its tools are prepared to extract digital fingerprints from an existing database of contraband; and used to scan seized computers, hard drives, and media devices (or forensic images of them) for contraband, as well as deliver results from those devices. The company’s tools provide results that allow forensic analysts to focus their investigative efforts on devices that yield useful evidence; avoid wasting time on devices that do not contain anything incriminating; and detailed evidence for use in court. The company was founded in 2016 and is based in Edinburgh, United Kingdom.

Manus Neurodynamica

Venture Round in 2021
Manus Neurodynamica Ltd manufactures medical diagnostic technologies for neuromotor impairments, including the non-invasive diagnosis and monitoring of Parkinson’s disease. Its technologies are used in academic research, pharmaceutical research, and non-medical applications. The company was founded in 2008 and is based in North Shields, United Kingdom.

Dxcover

Seed Round in 2020
It is our mission to be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life. Dxcover are an award-winning team, dedicated to developing liquid biopsies for early detection of cancer and other diseases. A University of Strathclyde spinout in 2019 under the name ClinSpec Diagnostics, and rebranded as Dxcover Limited in 2021. To date, Dxcover have secured £5.1m of funding, and have successfully completed two ground-breaking clinical studies on detection of brain cancer and are currently developing our platform for the detection of commonly occurring cancers.

Trojan Energy

Seed Round in 2020
Trojan Energy Limited provides charging infrastructure solutions for electric vehicles worldwide. The company offers on-street flat and flush electric vehicle charging points. Trojan Energy Limited was incorporated in 2016 and is based in Stonehaven, United Kingdom.

Cyan Forensics

Venture Round in 2019
CYAN FORENSICS Ltd. develops and markets tools for digital forensics in law enforcement. Its tools are prepared to extract digital fingerprints from an existing database of contraband; and used to scan seized computers, hard drives, and media devices (or forensic images of them) for contraband, as well as deliver results from those devices. The company’s tools provide results that allow forensic analysts to focus their investigative efforts on devices that yield useful evidence; avoid wasting time on devices that do not contain anything incriminating; and detailed evidence for use in court. The company was founded in 2016 and is based in Edinburgh, United Kingdom.

Talking Medicines

Seed Round in 2019
Talking Medicines Limited is a data technology company based in Glasgow and London that specializes in capturing and structuring the patient voice regarding medications. Utilizing advanced artificial intelligence, machine learning, and natural language processing, the company collects data from real-world conversations, social media, and connected devices to understand patient behaviors and sentiments. Its flagship application, Medsmart, gathers insights on how and why individuals take their medications. Talking Medicines offers a suite of solutions, including a real-world persona data service for ongoing updates, a digital focus group tool for surveys and A/B testing, and custom solutions tailored to specific pharmaceutical needs. The company primarily serves the pharmaceutical and healthcare sectors, helping them measure patient confidence and identify trends to enhance marketing strategies. Established in 2013 and initially known as Virtual Genie Limited, the company rebranded in December 2015.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.